CNA938 Rewind - Impact of planned Trump tariffs on pharmaceutical imports
Pharmaceuticals were exempt from sweeping tariffs on US imports recently announced by President Donald Trump but he has said they will face separate tariffs. Andrea Heng and Hairianto Diman examine the impact of these planned tariffs and to what extent this move will benefit America’s pharma industry with Evan Seigerman, Head of Healthcare Research, BMO Capital Markets
Resume
Pause
10 min